Therapeutic innovation for male fertility
PROKREA is developing a drug formulated as a vaginal gel that acts directly on sperm with the aim of improving sperm motility and facilitating fertiliszation in patients with male infertility.
WHO WE ARE
Prokrea is a biotechnology company founded in 2014, committed to improving male infertility.
THE PROJECT
The vaginal gel aims to increase sperm motility and help facilitate fertiliszation in cases of male infertility.